Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 180, Issue 5, Pages 2009-2017Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2012.01.012
Keywords
-
Categories
Funding
- NIH [K08 AI076616]
- Fort Dodge Animal Health Fellowship in Veterinary Medicine
Ask authors/readers for more resources
Co-infection of C3HeB/FeJ (C3H) mice with both Leishmania major and Leishmania amazonensis leads to a healed footpad lesion, whereas co-infection of C57BL/6 (B6) mice leads to non-healing lesions. This inability to heal corresponds to a deficiency in B cell stimulation of the macrophage-mediated killing of L amazonensis in vitro and a less robust antibody response. The mechanism that leads to healing of these lesions is not completely known, although our studies implicate the B cell response as having an important effector function in killing L amazonensis. To understand more completely this disparate clinical outcome to the same infection, we analyzed the draining lymph node germinal center B cell response between co-infected C3H and B6 mice. There were more germinal center B cells, more antibody isotype-switched germinal center B cells, more memory B cells, and more antigen-specific antibody-producing cells in co-infected C3H mice compared to B6 mice as early as 2 weeks postinfection. Interleukin (IL)-21 production and IL-21 receptor expression in both mouse strains, however, were similar at 2 weeks, suggesting that the difference in the anti-Leishmania response in these mouse strains may be due to differences in T follicular cell commitment or intrinsic B cell differences. These data support the idea that functional B cells are important for healing L amazonensis in this infectious disease model. (Am J Pathol 2012, 180: 2009-2017; DOI: 10.1016/j.ajpath.2012.01.012)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available